216 related articles for article (PubMed ID: 28833982)
1. The N-Terminal Domain of ALS-Linked TDP-43 Assembles without Misfolding.
Tsoi PS; Choi KJ; Leonard PG; Sizovs A; Moosa MM; MacKenzie KR; Ferreon JC; Ferreon ACM
Angew Chem Int Ed Engl; 2017 Oct; 56(41):12590-12593. PubMed ID: 28833982
[TBL] [Abstract][Full Text] [Related]
2. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.
Mompeán M; Romano V; Pantoja-Uceda D; Stuani C; Baralle FE; Buratti E; Laurents DV
J Biol Chem; 2017 Jul; 292(28):11992-12006. PubMed ID: 28566288
[TBL] [Abstract][Full Text] [Related]
3. Folding of the RNA recognition motif (RRM) domains of the amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 reveals an intermediate state.
Mackness BC; Tran MT; McClain SP; Matthews CR; Zitzewitz JA
J Biol Chem; 2014 Mar; 289(12):8264-76. PubMed ID: 24497641
[TBL] [Abstract][Full Text] [Related]
4. The Folding and Aggregation Energy Landscapes of Tethered RRM Domains of Human TDP-43 Are Coupled via a Metastable Molten Globule-like Oligomer.
Pillai M; Jha SK
Biochemistry; 2019 Feb; 58(6):608-620. PubMed ID: 30520297
[TBL] [Abstract][Full Text] [Related]
5. Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals.
Tamaki Y; Shodai A; Morimura T; Hikiami R; Minamiyama S; Ayaki T; Tooyama I; Furukawa Y; Takahashi R; Urushitani M
Sci Rep; 2018 Apr; 8(1):6030. PubMed ID: 29662239
[TBL] [Abstract][Full Text] [Related]
6. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.
Johnson BS; Snead D; Lee JJ; McCaffery JM; Shorter J; Gitler AD
J Biol Chem; 2009 Jul; 284(30):20329-39. PubMed ID: 19465477
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA.
Qin H; Lim LZ; Wei Y; Song J
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18619-24. PubMed ID: 25503365
[TBL] [Abstract][Full Text] [Related]
8. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing.
Wang A; Conicella AE; Schmidt HB; Martin EW; Rhoads SN; Reeb AN; Nourse A; Ramirez Montero D; Ryan VH; Rohatgi R; Shewmaker F; Naik MT; Mittag T; Ayala YM; Fawzi NL
EMBO J; 2018 Mar; 37(5):. PubMed ID: 29438978
[TBL] [Abstract][Full Text] [Related]
9. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-binding protein 43 (TDP-43).
Prakash A; Kumar V; Meena NK; Hassan MI; Lynn AM
J Biomol Struct Dyn; 2019 Jan; 37(1):178-194. PubMed ID: 29279008
[TBL] [Abstract][Full Text] [Related]
11. ALS-causing cleavages of TDP-43 abolish its RRM2 structure and unlock CTD for enhanced aggregation and toxicity.
Wei Y; Lim L; Wang L; Song J
Biochem Biophys Res Commun; 2017 Apr; 485(4):826-831. PubMed ID: 28257838
[TBL] [Abstract][Full Text] [Related]
12. Insight into the Folding and Dimerization Mechanisms of the N-Terminal Domain from Human TDP-43.
Vivoli-Vega M; Guri P; Chiti F; Bemporad F
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872449
[TBL] [Abstract][Full Text] [Related]
13. Structural heterogeneity in RNA recognition motif 2 (RRM2) of TAR DNA-binding protein 43 (TDP-43): clue to amyotrophic lateral sclerosis.
Prakash A; Kumar V; Banerjee A; Lynn AM; Prasad R
J Biomol Struct Dyn; 2021 Jan; 39(1):357-367. PubMed ID: 31914861
[TBL] [Abstract][Full Text] [Related]
14. Phase to Phase with TDP-43.
Sun Y; Chakrabartty A
Biochemistry; 2017 Feb; 56(6):809-823. PubMed ID: 28112502
[TBL] [Abstract][Full Text] [Related]
15. The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43.
Li HR; Chen TC; Hsiao CL; Shi L; Chou CY; Huang JR
Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):214-223. PubMed ID: 28988034
[TBL] [Abstract][Full Text] [Related]
16. The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity.
Chang CK; Wu TH; Wu CY; Chiang MH; Toh EK; Hsu YC; Lin KF; Liao YH; Huang TH; Huang JJ
Biochem Biophys Res Commun; 2012 Aug; 425(2):219-24. PubMed ID: 22835933
[TBL] [Abstract][Full Text] [Related]
17. Conversion of the Native N-Terminal Domain of TDP-43 into a Monomeric Alternative Fold with Lower Aggregation Propensity.
Moretti M; Marzi I; Cantarutti C; Vivoli Vega M; Mandaliti W; Mimmi MC; Bemporad F; Corazza A; Chiti F
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807552
[TBL] [Abstract][Full Text] [Related]
18. A Computational Approach to Investigate TDP-43 RNA-Recognition Motif 2 C-Terminal Fragments Aggregation in Amyotrophic Lateral Sclerosis.
Grassmann G; Miotto M; Di Rienzo L; Salaris F; Silvestri B; Zacco E; Rosa A; Tartaglia GG; Ruocco G; Milanetti E
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944548
[TBL] [Abstract][Full Text] [Related]
19. A novel mechanism for ATP to enhance the functional oligomerization of TDP-43 by specific binding.
Wang L; Lim L; Dang M; Song J
Biochem Biophys Res Commun; 2019 Jun; 514(3):809-814. PubMed ID: 31079926
[TBL] [Abstract][Full Text] [Related]
20. From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis.
Grad LI; Fernando SM; Cashman NR
Neurobiol Dis; 2015 May; 77():257-65. PubMed ID: 25701498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
